BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Healthcare

Otsuka Advances Centanafadine With FDA Filing To Bring a First in Class ADHD Therapy to Children, Adolescents, and Adults

Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents, and adults. It is a first-in-class norepinephrine, dop...

November 26, 2025 | News

Sanofi and AstraZeneca’s Beyfortus Gains Malaysia Approval to Protect All Infants from RSV

Beyfortus® (nirsevimab) is an available option designed to protect all infants – whether born full-term or pre-term, healthy or with underlying...

November 25, 2025 | News

HoneyNaps Drives Faster Clinical Trials with FDA Cleared AI Sleep Analysis Platform

Enhancing Clinical Efficiency with AI Sleep Analysis: Cutting Both Cost and Time Joint Clinical Studies with CROs: SOMNUM™ AI Sleep Scoring D...

November 25, 2025 | News

Aspen Neuroscience Secures $115 Million Series C to Advance Personalised Cell Therapy for Parkinson’s Disease

Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, announced the closing of a $115 millio...

November 21, 2025 | News

Guided Therapeutics Secures New LuViva Supply Agreement to Expand Cervical Cancer Screening Reach in China

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had completed an initial supply agreement with Yuansh...

November 21, 2025 | News

Genesis MedTech And NUHS Launch AI Innovation Partnership To Advance The Future Of Surgery

Genesis MedTech Group and the National University Health System (NUHS) have formed a strategic partnership to advance artificial intelligence (AI...

November 19, 2025 | News

Project ACTIVE Two Point Zero Launches to Strengthen Cervical Cancer Care Across Southeast Asia

A major step forward in regional collaboration for cancer care was announced today with the launch of Project ACTIVE 2.0 (Advancing Cervical Cancer Tr...

November 14, 2025 | News

Agilent and NHCS Forge Five Year Partnership To Advance Metabolic Heart Failure Research

Agilent Technologies Inc. (NYSE: A) announced the signing of a five-year Memorandum of Understanding (MOU) with National Heart Centre Singapore (...

November 14, 2025 | News

Utah’s Co-Diagnostics Expands Global Footprint with Saudi Joint Venture

Governor Spencer Cox joins Kelvyn Cullimore of BioUtah in recognizing Co-Diagnostics, Inc. (Nasdaq: CODX), a Utah diagnostics company with a...

November 13, 2025 | News

Medit and OraQ Announce Strategic Partnership to Advance AI-Driven Intelligence in Digital Dentistry

The partnership brings together Medit's open, global digital platform and OraQ's advanced AI technologies to create new pathways for innovation and connect...

November 13, 2025 | News

Muna Therapeutics Doses First Subjects in Phase 1 Trial of TREM2 Agonist MNA-001 for Alzheimer’s Disease

MNA-001 has best-in-class potential based on preclinical data demonstrating ability to significantly reduce neurotoxic amyloid burden and reprogram microgl...

November 11, 2025 | News

Takeda’s Mezagitamab Shows Sustained Kidney Function and Proteinuria Reduction Through 18-Month Follow-Up in IgA Nephropathy

Phase 1b, Open-Label Study Follow Up Shows Stable Kidney Function (eGFR) in Patients Treated with Investigational Mezagitamab Through Week 96 – 18 ...

November 10, 2025 | News

Eyexora Establishes Co-Headquarters in Singapore to Drive Global Ophthalmic Innovation

-Eyexora, a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model, announced the establishment of its co-he...

November 07, 2025 | News

PolyActiva and RareSight Forge Strategic Partnership to Develop Sustained-Release Therapies for Rare Pediatric Retinal Diseases

Partnership Leverages PolyActiva’s PREZIA™ Drug Delivery Platform Technology and RareSight’s Expertise in Rare Diseases to Advance Nove...

November 07, 2025 | News

Stay Connected